RARE
Ultragenyx Pharmaceutical Inc.
+0.60 (+4.66%)13.48USD1.6M成交股數1.3B市值–本益比(近四季)1.9股價營收比+28.1%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 214M+54% | 136M-17% | 160M+15% | 167M+14% | 139M+28% | 165M+68% | 139M+29% | 147M+46% | 109M | 98.1M | 108M | 100M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 167M | 187M | 216M | 165M | 166M | 188M | 170M | 162M | 178M | 157M | 165M | 166M |
| 銷售管理費用 | 88.0M | 88.0M | 86.6M | 87.0M | 87.0M | 81.9M | 80.4M | 80.6M | 78.2M | 74.9M | 81.4M | 76.6M |
| 營業利益 | −75.0M-48% | −169M+38% | −171M+29% | −108M-7% | −143M-14% | −122M-16% | −132M-11% | −116M-24% | −165M | −145M | −148M | −154M |
| 營業利益率 | -35.0% | -124.3% | -106.9% | -64.7% | -102.9% | -74.3% | -94.6% | -79.1% | -151.9% | -148.0% | -136.6% | -153.3% |
| 稅後淨利 | −92.0M-39% | −185M+39% | −180M+35% | −115M-13% | −151M-12% | −133M-17% | −134M-16% | −132M-20% | −171M | −160M | −160M | −164M |
| 淨利率 | -43.0% | -136.0% | -112.8% | -68.9% | -108.6% | -80.9% | -95.7% | -89.5% | -156.8% | -162.8% | -147.6% | -163.2% |
| 稀釋 EPS | -0.90-43% | -1.84+37% | -1.81+29% | -1.17-23% | -1.57-23% | -1.34-40% | -1.40-38% | -1.52-35% | -2.03 | -2.23 | -2.25 | -2.33 |
| 稀釋股數 | 102M | 101M | 99.8M | 98.5M | 96.3M | 90.5M | 95.5M | 86.6M | 84.3M | 71.7M | 70.9M | 70.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 125M | 175M | 203M | 176M | 127M | 174M | 151M | 481M | 112M | 72.6M | 102M | 85.8M |
| 應收帳款 | 200M | 121M | 113M | 124M | 98.8M | 122M | 93.3M | 106M | 100M | 79.3M | 70.5M | 43.0M |
| 存貨 | 59.0M | 55.0M | 52.2M | 46.5M | 46.0M | 45.0M | 43.3M | 40.1M | 35.9M | 31.8M | 28.3M | 26.6M |
| 總資產 | 1.3B | 1.3B | 1.2B | 1.3B | 1.3B | 1.5B | 1.5B | 1.6B | 1.3B | 1.2B | 1.3B | 1.4B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.5B | 1.5B | 1.2B | 1.1B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| 股東權益 | −291M | −236M | 9.2M | 151M | 144M | 255M | 347M | 432M | 140M | 31.7M | 129M | 220M |
| 負債比 | 122.5% | 117.7% | 98.6% | 87.9% | 88.5% | 82.6% | 77.0% | 73.3% | 89.3% | 97.4% | 90.2% | 84.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −197M | – | – | −166M-13% | – | – | – | −191M | – | – | −157M |
| 資本支出 | – | 1.0M | – | – | 1.0M | – | – | – | 3.2M | – | – | 25.0M |
| 自由現金流 | – | −198M | – | – | −167M-14% | – | – | – | −194M | – | – | −182M |
| 折舊攤銷 | – | 8.0M | – | – | 9.0M | – | – | – | 8.8M | – | – | 5.2M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -145.6% | – | – | -120.1% | – | – | – | -178.2% | – | – | -181.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 673M
| North America | 377M | 56.0% | +10.9% |
|---|---|---|---|
| Latin America | 170M | 25.3% | +29.8% |
| 歐洲中東非洲 | 108M | 16.0% | +35.0% |
| 亞太 | 18.0M | 2.7% | +100.0% |
產品／服務2025 年度 · 673M
| 產品 | 369M | 54.8% | +29.5% |
|---|---|---|---|
| Royalty | 304M | 45.2% | +10.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 673M | +20.2% | −575M | -85.4% | -5.83 | −472M |
| FY2024 | 560M | +29.0% | −569M | -101.6% | -6.29 | −421M |
| FY2023 | 434M | +19.5% | −607M | -139.9% | -8.25 | −519M |
| FY2022 | 363M | +3.4% | −707M | -194.7% | -10.12 | −497M |
| FY2021 | 351M | +29.7% | −454M | -129.2% | -6.70 | −412M |
| FY2020 | 271M | +161.3% | −187M | -68.8% | -3.07 | −176M |
| FY2019 | 104M | +101.4% | −403M | -388.3% | -7.12 | −370M |
| FY2018 | 51.5M | – | −198M | -383.7% | -3.97 | −295M |